{{Rsnum
|rsid=12800450
|Chromosome=11
|Orientation=plus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=SLC22A12
|position=64591749
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=SLC22A12
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 98.3 | 1.7 | 0.0
| HCB | 97.7 | 2.3 | 0.0
| JPT | 92.7 | 7.3 | 0.0
| YRI | 98.2 | 1.8 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 97.7 | 2.3 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21768215
|Trait=None
|Title=Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele.
|RiskAllele=T
|Pval=3E-16
|OR=1.1900
|ORtxt=[NR] mg/dl decrease
|OA=1
}}